Literature DB >> 6466591

The objective assessment of contrast sensitivity function by electrophysiological means.

J W Howe, K W Mitchell.   

Abstract

In recent years it has been shown that it is of considerable clinical value to determine the visual contrast sensitivity function of the patient. This can reveal the wider effects of pathology on the visual system where visual acuity may or may not be affected. There is a comprehensive literature on subjective approaches of obtaining this function in the clinical environment but very little on alternative objective methods. This paper describes the latter approach, which exploits electrophysiological techniques using the visual evoked cortical potential (VECP) to checkerboard onset-offset stimulation. Its application in a variety of disorders of the visual system is described. The importance of selecting the most appropriate stimulus parameters is discussed, and the relative advantages and disadvantages as compared with psychophysical methods are appraised.

Entities:  

Mesh:

Year:  1984        PMID: 6466591      PMCID: PMC1040430          DOI: 10.1136/bjo.68.9.626

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  60 in total

1.  Recent attempts to link psychophysics with neurophysiology in vision research.

Authors:  F W Campbell
Journal:  Trans Ophthalmol Soc U K       Date:  1979

2.  A pilot study of contrast sensitivity assessment of the CAM treatment of amblyopia.

Authors:  G C Woo; C C Dalziel
Journal:  Acta Ophthalmol (Copenh)       Date:  1981-02

3.  Eccentric contrast sensitivity loss in glaucoma.

Authors:  B L Lundh; G Lennerstrand
Journal:  Acta Ophthalmol (Copenh)       Date:  1981-02

4.  Utility of the Arden grating test in glaucoma screening: high false-positive rate in normals over 50 years of age.

Authors:  S Sokol; A Domar; A Moskowitz
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-12       Impact factor: 4.799

5.  Scotopic contrast sensitivity in infants evaluated by evoked potentials.

Authors:  A Fiorentini; M Pirchio; D Spinelli
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-08       Impact factor: 4.799

6.  Human aging and spatial vision.

Authors:  R Sekuler; L P Hutman; C J Owsley
Journal:  Science       Date:  1980-09-12       Impact factor: 47.728

7.  Contrast sensitivity assessment of functional amblyopia in humans.

Authors:  R F Hess
Journal:  Trans Ophthalmol Soc U K       Date:  1979

8.  Comparison of Snellen acuity, VER acuity, and Arden grating scores in macular and optic nerve diseases.

Authors:  H W Skalka
Journal:  Br J Ophthalmol       Date:  1980-01       Impact factor: 4.638

9.  Loss of contrast sensitivity following contusional eye injury.

Authors:  Y Canavan; D B Archer
Journal:  Br J Ophthalmol       Date:  1980-08       Impact factor: 4.638

10.  Contrast sensitivity in children with strabismic and anisometropic amblyopia. A study of the effect of treatment.

Authors:  J Sjöstrand
Journal:  Acta Ophthalmol (Copenh)       Date:  1981-02
View more
  11 in total

1.  Assessment of patients with suspected non-organic visual loss using pattern appearance visual evoked potentials.

Authors:  Vikki A McBain; Anthony G Robson; Chris R Hogg; Graham E Holder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-17       Impact factor: 3.117

2.  Objective measurement of contrast sensitivity function using contrast sweep visual evoked responses.

Authors:  J M Lopes de Faria; O Katsumi; M Arai; T Hirose
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

3.  A comparison of the performance of three visual evoked potential-based methods to estimate visual acuity.

Authors:  Anne Kurtenbach; Hana Langrová; Andre Messias; Eberhart Zrenner; Herbert Jägle
Journal:  Doc Ophthalmol       Date:  2012-11-11       Impact factor: 2.379

4.  Visual evoked potential and psychophysical contrast thresholds in glaucoma.

Authors:  Siti Nurliyana Abdullah; Gordon F Sanderson; Andrew C James; Ted Maddess
Journal:  Doc Ophthalmol       Date:  2014-03-11       Impact factor: 2.379

5.  The visual evoked potential in acute primary angle closure glaucoma.

Authors:  K W Mitchell; C M Wood; J W Howe; W H Church; G T Smith; S R Spencer
Journal:  Br J Ophthalmol       Date:  1989-06       Impact factor: 4.638

6.  Visual evoked potential latency and contrast sensitivity in patients with posterior chamber intraocular lens implants.

Authors:  J W Howe; K W Mitchell; M Mahabaleswara; M N Abdel-Khalek
Journal:  Br J Ophthalmol       Date:  1986-12       Impact factor: 4.638

7.  First-order Wiener kernel visually evoked potentials obtained from multiple sclerosis patients.

Authors:  D V Schoon; E K Wong
Journal:  Doc Ophthalmol       Date:  1987-01       Impact factor: 2.379

8.  CMSS-VEPs: contrast modulated steady state visual evoked potentials: its neuronal origin and clinical use.

Authors:  W Spileers; G A Orban; H Maes; L Missotten
Journal:  Doc Ophthalmol       Date:  1988 Mar-Apr       Impact factor: 2.379

9.  Visual evoked cortical potential to paracentral retinal stimulation in chronic glaucoma, ocular hypertension, and an age-matched group of normals.

Authors:  J W Howe; K W Mitchell
Journal:  Doc Ophthalmol       Date:  1986-06-16       Impact factor: 2.379

10.  Electrophysiologically determined contrast sensitivity in patients with ocular hypertension and chronic glaucoma.

Authors:  J W Howe; K W Mitchell
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.